Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms.

Cove CL, Albert CM, Andreotti F, Badimon L, Van Gelder IC, Hylek EM.

Thromb Haemost. 2014 Mar 3;111(3):385-91. doi: 10.1160/TH13-04-0347. Epub 2013 Dec 5.

PMID:
24305974
[PubMed - in process]
2.

Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.

Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GY, Bollmann A.

Circ Arrhythm Electrophysiol. 2013 Oct;6(5):868-74. doi: 10.1161/CIRCEP.113.000869. Epub 2013 Sep 18.

PMID:
24047706
[PubMed - indexed for MEDLINE]
3.

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.

Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY.

Thromb Haemost. 2012 Jun;107(6):1172-9. doi: 10.1160/TH12-03-0175. Epub 2012 Apr 3.

PMID:
22473219
[PubMed - indexed for MEDLINE]
4.

Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.

Potpara TS, Polovina MM, Licina MM, Marinkovic JM, Prostran MS, Lip GY.

Circ Arrhythm Electrophysiol. 2012 Apr;5(2):319-26. doi: 10.1161/CIRCEP.111.966713. Epub 2012 Feb 8.

PMID:
22319004
[PubMed - indexed for MEDLINE]
Free Article
5.

The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke.

Zuo ML, Liu S, Chan KH, Lau KK, Chong BH, Lam KF, Chan YH, Lau YF, Lip GY, Lau CP, Tse HF, Siu CW.

J Interv Card Electrophysiol. 2013 Jun;37(1):47-54. doi: 10.1007/s10840-012-9776-0. Epub 2013 Feb 7.

PMID:
23389054
[PubMed - indexed for MEDLINE]
6.

Stroke Prevention in Atrial Fibrillation [Internet].

Lopes RD, Crowley MJ, Shah BR, Melloni C, Wood KA, Chatterjee R, Povsic TJ, Dupre ME, Kong DF, de Barros e Silva PGM, dos Santos MHH, Armaganijan LV, Katz M, Kosinski A, McBroom AJ, Chobot MM, Gray R, Sanders GD.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Aug.

PMID:
24049843
[PubMed]
Books & Documents
7.

Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.

Taillandier S, Olesen JB, Clémenty N, Lagrenade I, Babuty D, Lip GY, Fauchier L.

J Cardiovasc Electrophysiol. 2012 Jul;23(7):708-13. doi: 10.1111/j.1540-8167.2011.02257.x. Epub 2012 Jan 23.

PMID:
22268375
[PubMed - indexed for MEDLINE]
8.

Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?

Roldán V, Marín F, Manzano-Fernandez S, Fernández H, Gallego P, Valdés M, Vicente V, Lip GY.

Thromb Haemost. 2013 May;109(5):956-60. doi: 10.1160/TH13-01-0054. Epub 2013 Mar 21.

PMID:
23572113
[PubMed - indexed for MEDLINE]
9.

Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.

Banerjee A, Fauchier L, Vourc'h P, Andres CR, Taillandier S, Halimi JM, Lip GY.

J Am Coll Cardiol. 2013 May 21;61(20):2079-87. doi: 10.1016/j.jacc.2013.02.035. Epub 2013 Mar 21.

PMID:
23524209
[PubMed - indexed for MEDLINE]
Free Article
10.

Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.

Roldán V, Marín F, Muiña B, Torregrosa JM, Hernández-Romero D, Valdés M, Vicente V, Lip GY.

J Am Coll Cardiol. 2011 Jun 21;57(25):2496-504. doi: 10.1016/j.jacc.2010.12.033. Epub 2011 Apr 14.

PMID:
21497043
[PubMed - indexed for MEDLINE]
Free Article
11.

A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.

Singer DE, Chang Y, Borowsky LH, Fang MC, Pomernacki NK, Udaltsova N, Reynolds K, Go AS.

J Am Heart Assoc. 2013 Jun 21;2(3):e000250. doi: 10.1161/JAHA.113.000250.

PMID:
23782923
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.

Saliba W, Rennert G.

Am J Med. 2014 Jan;127(1):45-52. doi: 10.1016/j.amjmed.2013.10.004. Epub 2013 Oct 15.

PMID:
24384101
[PubMed - indexed for MEDLINE]
13.

Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data.

Hughes M, Lip GY; Guideline Development Group, National Clinical Guideline for Management of Atrial Fibrillation in Primary and Secondary Care, National Institute for Health and Clinical Excellence.

Thromb Haemost. 2008 Feb;99(2):295-304. doi: 10.1160/TH07-08-0508. Review.

PMID:
18278178
[PubMed - indexed for MEDLINE]
14.

The CHADS₂versus the new CHA2DS2-VASc scoring systems for guiding antithrombotic treatment of patients with atrial fibrillation: review of the literature and recommendations for use.

Odum LE, Cochran KA, Aistrope DS, Snella KA.

Pharmacotherapy. 2012 Mar;32(3):285-96. doi: 10.1002/j.1875-9114.2012.01023.x. Review.

PMID:
22392459
[PubMed - indexed for MEDLINE]
15.

Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients.

Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA.

Europace. 2014 Feb;16(2):195-201. doi: 10.1093/europace/eut244. Epub 2013 Sep 12.

PMID:
24036378
[PubMed - in process]
Free PMC Article
16.

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.

Friberg L, Rosenqvist M, Lip GY.

Eur Heart J. 2012 Jun;33(12):1500-10. doi: 10.1093/eurheartj/ehr488. Epub 2012 Jan 13.

PMID:
22246443
[PubMed - indexed for MEDLINE]
Free Article
17.

Comparison of clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation.

Aakre CA, McLeod CJ, Cha SS, Tsang TS, Lip GY, Gersh BJ.

Stroke. 2014 Feb;45(2):426-31. doi: 10.1161/STROKEAHA.113.002585. Epub 2013 Dec 5.

PMID:
24309585
[PubMed - indexed for MEDLINE]
18.

[Cardioembolic stroke in atrial fibrillation and new anticoagulation criteria: a therapeutic dare].

Perez-Ortega I, Moniche-Alvarez F, Jimenez-Hernandez MD, Gonzalez-Marcos JR.

Rev Neurol. 2012 Jul 16;55(2):74-80. Spanish.

PMID:
22760766
[PubMed - indexed for MEDLINE]
Free Article
19.

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ.

Chest. 2010 Feb;137(2):263-72. doi: 10.1378/chest.09-1584. Epub 2009 Sep 17.

PMID:
19762550
[PubMed - indexed for MEDLINE]
20.

CHADS2 versus CHA2DS2-VASc score in assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: a systematic review and meta-analysis.

Chen JY, Zhang AD, Lu HY, Guo J, Wang FF, Li ZC.

J Geriatr Cardiol. 2013 Sep;10(3):258-66. doi: 10.3969/j.issn.1671-5411.2013.03.004.

PMID:
24133514
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk